Growth Metrics

Palvella Therapeutics (PVLA) Enterprise Value (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palvella Therapeutics 1.47 Bn 1.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -351.61%
Dec 31, 2025 8.79%
Sep 30, 2025 9.75%
Jun 30, 2025 6.87%
Mar 31, 2025 9.54%
Dec 31, 2024 -488.46%
Sep 30, 2024 2.27%
Jun 30, 2024 -132.67%
Mar 31, 2024 61.72%
Dec 31, 2023 71.23%
Sep 30, 2023 12.53%
Jun 30, 2023 -34.02%
Mar 31, 2023 18.24%
Dec 31, 2022 15.26%
Sep 30, 2022 13.73%
Jun 30, 2022 19.28%
Mar 31, 2022 14.86%
Dec 31, 2021 -237.43%
Sep 30, 2021 61.98%
Jun 30, 2021 -37.35%
Mar 31, 2021 5.11%
Dec 31, 2020 14.77%
Sep 30, 2020 -7.03%
Jun 30, 2020 11.01%
Mar 31, 2020 16.70%
Dec 31, 2019 -20.77%
Sep 30, 2019 13.48%
Jun 30, 2019 10.02%
Mar 31, 2019 11.50%
Dec 31, 2018 8.83%
Sep 30, 2018 9.06%
Jun 30, 2018 5.39%
Mar 31, 2018 -119.72%
Dec 31, 2017 19.23%
Sep 30, 2017 -78.68%
Jun 30, 2017 8.90%
Mar 31, 2017 -88.18%
Dec 31, 2016 19.70%
Sep 30, 2016 9.45%
Jun 30, 2016 -29.45%
Mar 31, 2016 -6.26%
Dec 31, 2015 9.01%
Sep 30, 2015 -221.67%
Jun 30, 2015 23.85%
Mar 31, 2015 28.73%
Dec 31, 2014 -1,873.35%
Sep 30, 2014 36.96%
Jun 30, 2014 54.59%
Mar 31, 2014 11.37%
Dec 31, 2013 -536,147.38%
Sep 30, 2013 86.77%